Back
BioMarin Pharmaceutical, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$55.50
Seasonality Move:
1.28%
7 Day Trial
ALL ACCESS PASS
$
7
BioMarin Pharmaceutical, Inc. Stock Forecast
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 15.3% based on the past 26 years of stock performance.
-
BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
-
Is BioMarin Pharmaceutical, Inc. Stock Undervalued?The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $55.50. The Score for BMRN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
BMRN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will BioMarin Pharmaceutical, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 15.3% based on the past 26 years of stock performance.
BioMarin Pharmaceutical, Inc. Stock Rating
Sell
29
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. overpriced?
-
BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
BioMarin Pharmaceutical, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
68.54
52-Week Low:
50.76
Prediction Charts
Market Cap:
10.3B
Price in USD:
55.50
Volume:
2.3M
Beta:
0.84
Technical Analysis
SMA50:
58.37
SMA100:
57.10
SMA200:
56.53
52-Wk Change:
-18.76%
Stock Predictions
-
Is BioMarin Pharmaceutical, Inc. stock public?Yes, BioMarin Pharmaceutical, Inc. is a publicly traded company.
-
What is the BioMarin Pharmaceutical, Inc. stock quote today?The BioMarin Pharmaceutical, Inc. stock price is 55.50 USD today.
-
How to buy BioMarin Pharmaceutical, Inc. stock online?You can buy BioMarin Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 56.71 | 57.43 | 58.81 | 55.86 |
| Mar-17 | 57.69 | 56.05 | 58.38 | 55.68 |
| Mar-18 | 55.60 | 55.43 | 56.28 | 54.82 |
| Mar-19 | 55.45 | 55.03 | 55.89 | 54.78 |
| Mar-20 | 54.86 | 54.13 | 55.71 | 53.76 |
| Mar-23 | 54.87 | 54.78 | 55.34 | 54.42 |
| Mar-24 | 54.36 | 54.09 | 54.37 | 53.36 |
| Mar-25 | 54.61 | 55.59 | 55.73 | 54.61 |
| Mar-26 | 55.36 | 55.55 | 56.06 | 55.20 |
| Mar-27 | 55.55 | 54.14 | 55.60 | 54.10 |
| Mar-30 | 54.42 | 54.79 | 55.00 | 53.94 |
| Mar-31 | 54.91 | 56.49 | 56.59 | 54.91 |
| Apr-1 | 56.72 | 57.24 | 57.50 | 56.28 |
| Apr-2 | 56.42 | 55.50 | 56.55 | 54.54 |
BioMarin Pharmaceutical, Inc. Earnings
BioMarin Pharmaceutical, Inc. Earnings Report: Per Share BioMarin Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioMarin Pharmaceutical, Inc. Forecast Revenue Growth
BioMarin Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for BioMarin Pharmaceutical, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.08 per share, an increase next quarter of $0.06 per share, an increase this year of $2.08 per share, and an increase next year of $1.39 per share.
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.